Trademark Search  /  STAR-CRISPR

STAR-CRISPR

● Live · Registered

U.S. federal trademark · Serial No. 79426106 · Reg. No. 8172915

Mark
STAR-CRISPR
Status
Registered
Serial Number
79426106
Registration No.
8172915
Filing Date
May 13, 2025
Registration Date
March 17, 2026
Class(es)
Class 001, Class 005, Class 040, Class 042

Owners

Celyntra Therapeutics SA
33 · BE
Celyntra Therapeutics SA
33 · BE
Celyntra Therapeutics SA
33 · BE

Goods & Services

Reagents for research purposes; reagents used in science; reagents for scientific purposes; reagents for medical research; laboratory reagents for scientific use; chemical reagents for scientific purposes; reagents for scientific or medical research use; chemical reagents for use in genetic research; chemical reagents for use in biotechnology, other than for medical or veterinary use; specialized reagents for genome editing for scientific, research, and laboratory use; modified cells, in particular genetically modified ips (induced pluripotent stem) cells and differentiated cells derived therefrom, for research or scientific purposes; cell cultures, cell culture systems and cryopreserved genetically modified ips cells for scientific and industrial research purposes; cell cultures, and cryopreserved cells ips cells other than for medical or veterinary use; Biological preparations for use in cell cultures, other than for medical or veterinary purposes, namely, cell culture agents for use in the biotechnology industry and cell material for use in combination with human cells, including genetically modified ips or differentiated stem cells

Medical diagnostic reagents; clinical medical reagents; clinical diagnostic reagents for medical use; reagents for use in medical genetic testing; cells for medical use; genetic identity tests comprised of reagents for medical purposes; specialized reagents for genome editing for medical and medical clinical use; modified cells, in particular genetically modified ips (induced pluripotent stem) cells and differentiated cells derived therefrom, for medical or veterinary use; cell cultures and cell culture systems, and cryopreserved pluripotent stem cells for medical or veterinary use; genetically modified ips (induced pluripotent stem) cells for use in generating other cells for therapeutic purposes; cell cultures and cell culture systems, and cryopreserved genetically modified pluripotent stem cells for sub cultivation of cells, for medical or veterinary use

Custom manufacturing of iPS derived cells, and iPS derived cell therapy and manufacturing processes for others, namely, manufacturing of the foregoing cells in GMP-based facilities; custom manufacture of therapeutic cells, medicines, cell therapies and gene edited cell therapies for others, including manufacturing in GMP-based facilities; custom manufacture of cellular therapies, including manufacturing in GMP-based facilities; manufacturing of cell lines being modified cells with specific genetic edits for use in generating other cells

Structural and functional analysis of genomes; research and development in the field of microorganisms and cells; research in the field of gene editing technology; genetic research; gene therapy research; scientific research in the field of genetics and genetic engineering; research in the field of gene therapy; research in the field of genetic diseases; scientific research relating to genetics; biotechnology research; biotechnology testing; preparation of reports in the biotechnology field; research and testing of cell-based products, in particular therapeutic products; research, optimization and testing of cell production processes; laboratory research in the field of biotechnology using genetically modified ips (induced pluripotent stem) cells and differentiated cells derived therefrom; scientific research, design and development of scientific cell culture, cell therapy and gene edited cell therapy; scientific research, design and development of cell culture, cell therapy and gene edited cell therapy, manufacturing systems and manufacturing processes for others; platform as a service (PAAS) services featuring computer software platforms for custom manufacturing of cell-based products in the field of cell therapy, and cell therapy development; providing temporary use of online non-downloadable computer software platform for the management of manufacturing of cell-based therapies, namely, the associated technology, processes, and data analytics capabilities for process optimization and quality control

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "STAR-CRISPR" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.